Is Duos Technologies Group (DUOT) a Mispriced Opportunity?
| | | |

Is Duos Technologies Group (DUOT) a Mispriced Opportunity?

Grow Funds, an investment Advisor, released its Q1 2026 investor letter for ā€œGROW Small Cap Equity Long/Short Fundā€. A copy of the letter can be downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index’s –2.80%, HFRI Equity Hedge Index’s -0.24%, and the HFRI Fundamental…

Tech stocks live: Tech stocks mixed ahead of Micron earnings Wednesday
| | | |

Tech stocks live: Tech stocks mixed ahead of Micron earnings Wednesday

Tech stocks were mixed in early trading Monday as questions continued to loom over the US-Iran peace deal. On the artificial intelligence front, memory giant Micron (MU) will report its third quarter earnings after the bell on Wednesday, providing another update on the broader AI build-out. On Monday, the company announced a strategic agreement with…

A US soldier was arrested for betting with classified intel — now regulators want to crack down on prediction markets
| | | |

A US soldier was arrested for betting with classified intel — now regulators want to crack down on prediction markets

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. As concerns grow surrounding the prediction market industry, the Commodity Futures Trading Commission (CFTC) has proposed new limits on what topics can and can’t be subject to wagers. While sports bettors might shrug, people who enjoy exploring the fringes…

BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline
| | | |

BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline

BeOne Medicines AG (NASDAQ:ONC) is one of the most promising healthcare stocks according to Wall Street analysts. On June 3, Citizens kept its Market Outperform rating and $396 price target on BeOne Medicines AG (NASDAQ:ONC). The firm made the call after BeOne presented robust tumor clinical data at the American Society of Clinical Oncology (ASCO)…

Alnylam (ALNY) Expands Its RNAi Therapeutics Reach Into Four More Nordic Countries
| | | |

Alnylam (ALNY) Expands Its RNAi Therapeutics Reach Into Four More Nordic Countries

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the most promising healthcare stocks according to Wall Street analysts. On June 10, GENESIS Pharma announced the expansion of its commercial partnership with Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) to cover four Nordic countries, that is, Sweden, Finland, Denmark, and Norway. GENESIS is an Athens-based biopharma company and the expanded…

Truist Cuts Boston Scientific (BSX) ’s Target as Doctors Change How They Use Its Heart Device
| | | |

Truist Cuts Boston Scientific (BSX) ’s Target as Doctors Change How They Use Its Heart Device

Boston Scientific Corporation (NYSE:BSX) is one of the most promising healthcare stocks according to Wall Street analysts. On June 4, Truist Securities lowered its price target on Boston Scientific Corporation (NYSE:BSX) from $85 to $64, while keeping its Buy rating on the stock. Richard Newitter, the analyst on record, cited a growing slowdown in demand…

Insulet (PODD): New Data Shows Its Next-Gen System Delivers Far More Automated Insulin
| | | |

Insulet (PODD): New Data Shows Its Next-Gen System Delivers Far More Automated Insulin

Insulet Corporation (NASDAQ:PODD) is one of the most promising healthcare stocks according to Wall Street analysts. On June 6, Insulet Corporation (NASDAQ:PODD) released new clinical results for two of its next-generation diabetes management systems, which management described as strong and that bring the company closer to making the systems a reality. Insulet (PODD): New Data…

Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?
| | | |

Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?

Insmed Incorporated (NASDAQ:INSM) is one of the most promising healthcare stocks according to Wall Street analysts. On June 10, Cantor Fitzgerald reaffirmed its Overweight rating on Insmed Incorporated (NASDAQ:INSM) and raised its price target from $230 to $235. Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise? The firm…

Analyst Report: Illinois Tool Works Inc
| | | |

Analyst Report: Illinois Tool Works Inc

Summary Founded in 1912, Illinois Tool Works Inc. is a global manufacturer of engineered industrial products and equipment. The company’s operations are divided into seven segments: Automotive OEM, TME, Food Equipment, P&F, Welding, Construction Products, and Specialty Products. The shares are

Michael Burry sees a  trillion problem with SpaceX
| | | |

Michael Burry sees a $3 trillion problem with SpaceX

SpaceX already nailed its first test stock market test. The tough question is whether investors can detach the stock from the company. Elon Musk’s rocket, satellite, and artificial intelligence company has become one of the most controversial new listings on the market after a record-breaking initial public offering and rapid ascent. The company’s story is…

End of content

End of content